Back

DAPT type and duration in ACS patients.

27 August 2017 (17:06 - 17:24)
Organised by:
Congress Presentation Part of: ESC Guidelines 2017 - Focused update on dual antiplatelet therapy developed in collaboration with EACTS PCI: primary PCI / patient subsets Open Access ESC Congress 2017

About the speaker

Photo
Professor Franz Josef Neumann

University Heart Centre Freiburg-Bad Krozingen, Bad Krozingen (Germany)

4 More presentations in this session

Presentation thumbnail
The long journey of DAPT: from stents to patients.
Professor H. Bueno (Madrid, ES)
Slides Video
Presentation thumbnail
DAPT type and duration in SCAD patients.
Professor M. Roffi (Geneva, CH)
Slides Video
Presentation thumbnail
DAPT type and duration in OAC patients.
Professor R. Byrne (Dublin, IE)
Slides Video
Presentation thumbnail
DAPT type, duration and management in surgical patients.
Professor A. Jeppsson (Gothenburg, SE)
Slides Video

Access the full session

Session thumbnail
ESC Guidelines 2017 - Focused update on dual antiplatelet therapy developed in collaboration with EACTS

The Event

Event poster

ESC Congress 2017

27 August 2017 17:06 CET
You may be interested in
thumbnail
Congress Presentation
Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens
1 September 2025
thumbnail
Congress Presentation
New insights into optimal duration of DAPT for high-risk "TWILIGHT-like" patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group
28 August 2021
thumbnail
Congress Presentation
When should we prolong DAPT beyond 12 months?
1 September 2024
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources